Voyager Acquisition Corp Unit
VACHUStock
$14.50
Market Cap$328.07M
P/E36.50x
Div yield—
Beta-0.29
Price Chart
Favorite Metrics
Price vs S&P 500 (26W)-89.09%
Price vs S&P 500 (4W)-89.77%
VGM Score15.22
Market Capitalization$328.07M
P/E Ratio (Annual)36.50x
Industry Peers — Biological Products(180)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
VACHUVoyager Acquisition Corp Unit | — | D | F | $14.50 |
| AMGNAmgen Inc | C | C | C | $371.58 |
| GILDGilead Sciences Inc | C | B | C | $136.30 |
| ARGXargenx SE American Depositary Shares | D | A | B | $857.97 |
| RVMDRevolution Medicines, Inc. Common Stock | F | — | A | $179.18 |
| BIIBBiogen Inc. Common Stock | B | D | B | $208.92 |
| BNTXBioNTech SE American Depositary Share | C | C | C | $91.56 |
| MRNAModerna, Inc. Common Stock | D | B | B | $63.15 |
| NBIXNeurocrine Biosciences Inc | C | B | B | $171.55 |
| EXELExelixis Inc | C | B | B | $55.68 |
| TECHBio-Techne Corp. | D | C | B | $71.77 |
About
Voyager Acquisition Corp is a blank check company established to acquire and merge with an operating business. The company seeks to identify and execute a strategic business combination in sectors that offer attractive investment opportunities for shareholders.